Gelesis

BOSTON--(BUSINESS WIRE)--Gelesis announced today that leading U.S. direct-to-patient healthcare company Ro has placed a $30 million fully paid pre-order for the company’s first commercial product for weight management, Plenity®.…

BOSTON--(BUSINESS WIRE)--PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company, noted today that its Founded Entity, Gelesis, Inc. (“Gelesis”) announced today a…

BOSTON--(BUSINESS WIRE)--Gelesis, a consumer-focused biotherapeutics company and the maker of Plenity®, announced that two senior leaders in the company, Elaine Chiquette, Pharm.D., and Elizabeth Pash, MS, RD, LDN, were…

BOSTON & AUSTIN, Texas--(BUSINESS WIRE)--Jul 19, 2021--Gelesis, Inc. (“Gelesis” or the “Company”), a…

BOSTON--(BUSINESS WIRE)--Jul 19, 2021--PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the…